InvestorsHub Logo
Followers 121
Posts 11266
Boards Moderated 0
Alias Born 01/20/2009

Re: None

Tuesday, 05/30/2017 7:36:13 AM

Tuesday, May 30, 2017 7:36:13 AM

Post# of 38634
With the aim of replacing its expiring shelf registration statement (June 4), Intellipharmaceutics International (NASDAQ:IPCI) files an F-3 with the SEC for a new $100M shelf offering. The company says it has no immediate plans to sell securities except possibly to sell additional common shares under its at-the-market equity program.